CDER E2B(R2) Combination Products
FDA published final guidance for Industry for Post Marketing Safety reporting for Combination Products in July 2019.
Oracle Argus Safety 8.2.2 provides features to configure and process cases with the combination products and report to FDA as per the latest regulations.
The following are the list of changes made in the release: